COM:IMCHECKTHERAPEUTICS
Imcheck Therapeutics
- Privately Held
locale
Francemarket
PRIVATEindustry
Biotechnologywebsite
imchecktherapeutics.comcrunchbase
imcheck-therapeuticslinkedin
imcheck-therapeuticsfounding date
Jan 01, 2015
Imcheck Therapeutics is a biotechnology company developing ICT41, a humanized anti-BTN3A monoclonal antibody that selectively activates γ9Vδ2 T cells to combat infectious diseases.